These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10100320)

  • 1. Enhanced accumulation of sialyl Lewis X-carboxymethylpullulan conjugate in acute inflammatory lesion.
    Horie K; Sakagami M; Kuramochi K; Hanasaki K; Hamana H; Ito T
    Pharm Res; 1999 Feb; 16(2):314-20. PubMed ID: 10100320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the sialyl Lewis X (SLe(x)) moiety on splenic accumulation of SLe(x)-carboxymethylpullulan conjugate.
    Horie K; Sakagami M; Kuramochi K; Ito T; Hamana H
    Microbiol Immunol; 2000; 44(5):401-4. PubMed ID: 10888360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of sialyl Lewis X-polysaccharide conjugates.
    Sakagami M; Horie K; Nakamoto K; Kawaguchi T; Hamana H
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1256-63. PubMed ID: 10993222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialyl Lewis X-carboxymethylpullulan conjugate: a novel homing device to spleen and lymph nodes.
    Horie K; Sakagami M; Masuda K; Notoya M; Hamana H; Yoshikawa T; Hirano K
    Biol Pharm Bull; 2004 Aug; 27(8):1275-80. PubMed ID: 15305036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialyl Lewis X-polysaccharide conjugates: targeting inflammatory lesions.
    Sakagami M; Horie K; Nakamoto K; Kawaguchi T; Hamana H
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2783-6. PubMed ID: 9873622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells.
    Welply JK; Abbas SZ; Scudder P; Keene JL; Broschat K; Casnocha S; Gorka C; Steininger C; Howard SC; Schmuke JJ
    Glycobiology; 1994 Jun; 4(3):259-65. PubMed ID: 7524825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo ligand specificity of E-selectin binding to multivalent sialyl Lewisx N-linked oligosaccharides.
    Thomas VH; Yang Y; Rice KG
    J Biol Chem; 1999 Jul; 274(27):19035-40. PubMed ID: 10383404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode.
    Renkonen O; Toppila S; Penttilä L; Salminen H; Helin J; Maaheimo H; Costello CE; Turunen JP; Renkonen R
    Glycobiology; 1997 Jun; 7(4):453-61. PubMed ID: 9184825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion.
    Turunen JP; Majuri ML; Seppo A; Tiisala S; Paavonen T; Miyasaka M; Lemström K; Penttilä L; Renkonen O; Renkonen R
    J Exp Med; 1995 Oct; 182(4):1133-41. PubMed ID: 7561686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher-affinity oligosaccharide ligands for E-selectin.
    Nelson RM; Dolich S; Aruffo A; Cecconi O; Bevilacqua MP
    J Clin Invest; 1993 Mar; 91(3):1157-66. PubMed ID: 7680663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution characteristics of carboxymethylpullulan-peptide-doxorubicin conjugates in tumor-bearing rats: different sequence of peptide spacers and doxorubicin contents.
    Nogusa H; Yamamoto K; Yano T; Kajiki M; Hamana H; Okuno S
    Biol Pharm Bull; 2000 May; 23(5):621-6. PubMed ID: 10823676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium.
    Seppo A; Turunen JP; Penttilä L; Keane A; Renkonen O; Renkonen R
    Glycobiology; 1996 Jan; 6(1):65-71. PubMed ID: 8991511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of carboxymethylpullulan as a novel carrier for targeting immune tissues.
    Masuda K; Sakagami M; Horie K; Nogusa H; Hamana H; Hirano K
    Pharm Res; 2001 Feb; 18(2):217-23. PubMed ID: 11405294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues.
    Munro JM; Lo SK; Corless C; Robertson MJ; Lee NC; Barnhill RL; Weinberg DS; Bevilacqua MP
    Am J Pathol; 1992 Dec; 141(6):1397-408. PubMed ID: 1281620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of the dynamic strength of the sialyl Lewis X--selectin interaction.
    Zhang X; Bogorin DF; Moy VT
    Chemphyschem; 2004 Feb; 5(2):175-82. PubMed ID: 15038277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion.
    Stahn R; Schäfer H; Kernchen F; Schreiber J
    Glycobiology; 1998 Apr; 8(4):311-19. PubMed ID: 9499378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on selectin-carbohydrate interactions.
    Jacob GS; Welply JK; Scudder PR; Kirmaier C; Abbas SZ; Howard SC; Keene JL; Schmuke JJ; Broschat K; Steininger C
    Adv Exp Med Biol; 1995; 376():283-90. PubMed ID: 8597260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-selectin ligands in rat high endothelium: multivalent sialyl Lewis x glycans are high-affinity inhibitors of lymphocyte adhesion.
    Toppila S; Lauronen J; Mattila P; Turunen JP; Penttilä L; Paavonen T; Renkonen O; Renkonen R
    Eur J Immunol; 1997 Jun; 27(6):1360-5. PubMed ID: 9209485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved in vivo antitumor efficacy and reduced systemic toxicity of carboxymethylpullulan-peptide-doxorubicin conjugates.
    Nogusa H; Hamana H; Uchida N; Maekawa R; Yoshioka T
    Jpn J Cancer Res; 2000 Dec; 91(12):1333-8. PubMed ID: 11123434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial targeting and enhanced antiinflammatory effects of complement inhibitors possessing sialyl Lewisx moieties.
    Mulligan MS; Warner RL; Rittershaus CW; Thomas LJ; Ryan US; Foreman KE; Crouch LD; Till GO; Ward PA
    J Immunol; 1999 Apr; 162(8):4952-9. PubMed ID: 10202042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.